Delivery Order SPE2DB22D3102-SPE2DB25FL2XD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,504.02 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30-count units). This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $15,164.14 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Hyzaar 50-12.5 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,155.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of HYZAAR 100-12.5, a combination antihypertensive medication, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued on August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $2,297.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Hyzaar 50-12.5, a combination antihypertensive medication. This non-set-aside competitive award was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $341,650 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561599439 HYZAAR 100-12.5 mg tablets. Under this order, Amerisourcebergen will deliver 90 tablets of the specified hypertension medication to a facility in Conshohocken, Pennsylvania by July 26, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 prime contractor on the Agency's Pharmaceutical Prime Vendor contract,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HYZAAR 50-12.5 tablets. The order has a completion date of January 31, 2024 and a potential value of $1,294.97. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up...
- This is a $1,592.43 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYZAAR 50-12.5 TABLET 90S, a medication, to support military and government healthcare programs. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,311.68, is for the delivery of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $1,467.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562321767 HYZAAR 100-25 TABLET 30S. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified hypertension medication to a facility in Conshohocken, Pennsylvania, completing performance within one day on September 28, 2023. No...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2XDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $3,693.91. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 10, 2025, and was awarded on a competitive basis without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDV serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for HYZAAR, a combination antihypertensive medication, exemplifies the routine pharmaceutical fulfillment the company provides under this strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/9/25 |